JP2010209076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010209076A5 JP2010209076A5 JP2010081265A JP2010081265A JP2010209076A5 JP 2010209076 A5 JP2010209076 A5 JP 2010209076A5 JP 2010081265 A JP2010081265 A JP 2010081265A JP 2010081265 A JP2010081265 A JP 2010081265A JP 2010209076 A5 JP2010209076 A5 JP 2010209076A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- amount
- expression level
- patient
- hya22
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims 14
- 238000000034 method Methods 0.000 claims 10
- -1 eIF5 Proteins 0.000 claims 8
- 230000014509 gene expression Effects 0.000 claims 6
- 102100039776 39S ribosomal protein L4, mitochondrial Human genes 0.000 claims 4
- 102100027674 CTD small phosphatase-like protein Human genes 0.000 claims 4
- 101000667416 Homo sapiens 39S ribosomal protein L4, mitochondrial Proteins 0.000 claims 4
- 101000725950 Homo sapiens CTD small phosphatase-like protein Proteins 0.000 claims 4
- 206010033128 Ovarian cancer Diseases 0.000 claims 4
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 4
- 238000003757 reverse transcription PCR Methods 0.000 claims 4
- 102100039725 AH receptor-interacting protein Human genes 0.000 claims 3
- 102000003900 Calpain-2 Human genes 0.000 claims 3
- 108090000232 Calpain-2 Proteins 0.000 claims 3
- 102000016589 Calponin-2 Human genes 0.000 claims 3
- 108050006169 Calponin-2 Proteins 0.000 claims 3
- 102100038712 Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 Human genes 0.000 claims 3
- 101000802964 Dendroaspis angusticeps Muscarinic toxin 1 Proteins 0.000 claims 3
- 102100029791 Double-stranded RNA-specific adenosine deaminase Human genes 0.000 claims 3
- 102100036498 Dual specificity testis-specific protein kinase 2 Human genes 0.000 claims 3
- 102000002639 Eukaryotic Initiation Factor-2B Human genes 0.000 claims 3
- 108010082945 Eukaryotic Initiation Factor-2B Proteins 0.000 claims 3
- 102100029531 Fas-activated serine/threonine kinase Human genes 0.000 claims 3
- 101710117201 Fas-activated serine/threonine kinase Proteins 0.000 claims 3
- 101150088682 HMT-1 gene Proteins 0.000 claims 3
- 102100034049 Heat shock factor protein 2 Human genes 0.000 claims 3
- 101000959526 Homo sapiens AH receptor-interacting protein Proteins 0.000 claims 3
- 101100490834 Homo sapiens ALG1 gene Proteins 0.000 claims 3
- 101000883304 Homo sapiens Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 Proteins 0.000 claims 3
- 101000865408 Homo sapiens Double-stranded RNA-specific adenosine deaminase Proteins 0.000 claims 3
- 101000714156 Homo sapiens Dual specificity testis-specific protein kinase 2 Proteins 0.000 claims 3
- 101001016883 Homo sapiens Heat shock factor protein 2 Proteins 0.000 claims 3
- 101000605522 Homo sapiens Kallikrein-1 Proteins 0.000 claims 3
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 claims 3
- 101000587539 Homo sapiens Metallothionein-1A Proteins 0.000 claims 3
- 101001027956 Homo sapiens Metallothionein-1B Proteins 0.000 claims 3
- 101001027945 Homo sapiens Metallothionein-1E Proteins 0.000 claims 3
- 101001027943 Homo sapiens Metallothionein-1F Proteins 0.000 claims 3
- 101001027938 Homo sapiens Metallothionein-1G Proteins 0.000 claims 3
- 101001013794 Homo sapiens Metallothionein-1H Proteins 0.000 claims 3
- 101001013797 Homo sapiens Metallothionein-1L Proteins 0.000 claims 3
- 101001013796 Homo sapiens Metallothionein-1M Proteins 0.000 claims 3
- 101001013799 Homo sapiens Metallothionein-1X Proteins 0.000 claims 3
- 101100404397 Homo sapiens NME4 gene Proteins 0.000 claims 3
- 101000582254 Homo sapiens Nuclear receptor corepressor 2 Proteins 0.000 claims 3
- 101100216116 Homo sapiens PRMT2 gene Proteins 0.000 claims 3
- 101000669667 Homo sapiens RNA-binding protein with serine-rich domain 1 Proteins 0.000 claims 3
- 101001130686 Homo sapiens Ras-related protein Rab-22A Proteins 0.000 claims 3
- 101000590687 Homo sapiens U3 small nucleolar ribonucleoprotein protein MPP10 Proteins 0.000 claims 3
- 101000782180 Homo sapiens WD repeat-containing protein 1 Proteins 0.000 claims 3
- 102100029228 Insulin-like growth factor-binding protein 7 Human genes 0.000 claims 3
- 102100034866 Kallikrein-6 Human genes 0.000 claims 3
- 102100029698 Metallothionein-1A Human genes 0.000 claims 3
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 claims 3
- 102100023609 Nucleoside diphosphate kinase, mitochondrial Human genes 0.000 claims 3
- 102100029796 Protein S100-A10 Human genes 0.000 claims 3
- 102100029811 Protein S100-A11 Human genes 0.000 claims 3
- 102100022988 Protein arginine N-methyltransferase 2 Human genes 0.000 claims 3
- 102100039323 RNA-binding protein with serine-rich domain 1 Human genes 0.000 claims 3
- 102100031516 Ras-related protein Rab-22A Human genes 0.000 claims 3
- 108091005487 SCARB1 Proteins 0.000 claims 3
- 102100037118 Scavenger receptor class B member 1 Human genes 0.000 claims 3
- 102100032497 U3 small nucleolar ribonucleoprotein protein MPP10 Human genes 0.000 claims 3
- 102100036551 WD repeat-containing protein 1 Human genes 0.000 claims 3
- 108010008598 insulin-like growth factor binding protein-related protein 1 Proteins 0.000 claims 3
- 210000003371 toe Anatomy 0.000 claims 3
- 238000011282 treatment Methods 0.000 claims 3
- 102100021676 Baculoviral IAP repeat-containing protein 1 Human genes 0.000 claims 2
- 102100022083 Grancalcin Human genes 0.000 claims 2
- 101710124985 Grancalcin Proteins 0.000 claims 2
- 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 claims 2
- 101001024605 Homo sapiens Next to BRCA1 gene 1 protein Proteins 0.000 claims 2
- 101150018665 MAPK3 gene Proteins 0.000 claims 2
- 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 108010006696 Neuronal Apoptosis-Inhibitory Protein Proteins 0.000 claims 2
- 102100037001 Next to BRCA1 gene 1 protein Human genes 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 108020004463 18S ribosomal RNA Proteins 0.000 claims 1
- 102100031109 Beta-catenin-like protein 1 Human genes 0.000 claims 1
- 101710164563 Beta-catenin-like protein 1 Proteins 0.000 claims 1
- 102100023479 Vinexin Human genes 0.000 claims 1
- 101710187710 Vinexin Proteins 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 101710185494 Zinc finger protein Proteins 0.000 claims 1
- 102100023597 Zinc finger protein 816 Human genes 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 102000042567 non-coding RNA Human genes 0.000 claims 1
- 238000007899 nucleic acid hybridization Methods 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53350503P | 2003-12-31 | 2003-12-31 | |
| US60/533,505 | 2003-12-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006547537A Division JP4682152B2 (ja) | 2003-12-31 | 2004-12-30 | 卵巣がんの化学療法に対する抵抗性を予測および克服するための方法ならびに結腸がんの発生を予測するための方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012271426A Division JP5789591B2 (ja) | 2003-12-31 | 2012-12-12 | がん細胞の化学療法に対する抵抗性を克服するための阻害因子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010209076A JP2010209076A (ja) | 2010-09-24 |
| JP2010209076A5 true JP2010209076A5 (enExample) | 2011-02-10 |
| JP5285012B2 JP5285012B2 (ja) | 2013-09-11 |
Family
ID=34748910
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006547537A Expired - Fee Related JP4682152B2 (ja) | 2003-12-31 | 2004-12-30 | 卵巣がんの化学療法に対する抵抗性を予測および克服するための方法ならびに結腸がんの発生を予測するための方法 |
| JP2010081265A Expired - Fee Related JP5285012B2 (ja) | 2003-12-31 | 2010-03-31 | 卵巣がんの化学療法に対する抵抗性を予測および克服するための方法ならびに結腸がんの発生を予測するための方法 |
| JP2012271426A Expired - Fee Related JP5789591B2 (ja) | 2003-12-31 | 2012-12-12 | がん細胞の化学療法に対する抵抗性を克服するための阻害因子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006547537A Expired - Fee Related JP4682152B2 (ja) | 2003-12-31 | 2004-12-30 | 卵巣がんの化学療法に対する抵抗性を予測および克服するための方法ならびに結腸がんの発生を予測するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012271426A Expired - Fee Related JP5789591B2 (ja) | 2003-12-31 | 2012-12-12 | がん細胞の化学療法に対する抵抗性を克服するための阻害因子 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US7700280B2 (enExample) |
| EP (2) | EP1704250B1 (enExample) |
| JP (3) | JP4682152B2 (enExample) |
| CN (3) | CN102989009B (enExample) |
| ES (1) | ES2394799T3 (enExample) |
| TW (1) | TWI301066B (enExample) |
| WO (1) | WO2005066371A2 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102989009B (zh) * | 2003-12-31 | 2015-06-03 | 宾夕法尼亚州研究基金会 | 预测并克服对卵巢癌化疗的抗性的方法及预测结肠癌发生的方法 |
| AU2006249235B2 (en) * | 2004-05-14 | 2010-11-11 | Abraxis Bioscience, Llc | Sparc and methods of use thereof |
| MXPA06013191A (es) * | 2004-05-14 | 2007-07-24 | Abraxis Bioscience Inc | Metodos de tratamiento que utilizan proteinas que enlazan albumina como objetivos. |
| US8420603B2 (en) * | 2004-05-14 | 2013-04-16 | Abraxis Bioscience, Llc | SPARC and methods of use thereof |
| US7553496B2 (en) * | 2004-12-21 | 2009-06-30 | University Of Kentucky Research Foundation | VEGF-A as an inhibitor of angiogenesis and methods of using same |
| US8445198B2 (en) | 2005-12-01 | 2013-05-21 | Medical Prognosis Institute | Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| JP5984324B2 (ja) * | 2005-12-01 | 2016-09-06 | メディカル プログノシス インスティテュート エー／エス | 治療反応のバイオマーカーを同定するための方法および装置、ならびに治療効果を推定するためのその使用 |
| WO2007146372A2 (en) * | 2006-06-13 | 2007-12-21 | The Rockefeller University | Novel therapeutic and diagnostic products and methods |
| DE102006035393A1 (de) * | 2006-11-02 | 2008-05-15 | Signature Diagnostics Ag | Prognostische Marker für die Klassifizierung des dreijährigen progessionsfreien Überlebens von Patienten mit Kolonkarzinomen basierend auf Expressionsprofilen von biologischen Proben |
| US20110178154A1 (en) * | 2007-02-06 | 2011-07-21 | Birrer Michael J | gene expression profile that predicts ovarian cancer subject response to chemotherapy |
| WO2008109519A2 (en) * | 2007-03-02 | 2008-09-12 | University Of South Florida | Micro-rna profiles associated with endometrial cancer development and response to cisplatin and doxorubicin chemotherapy |
| US8034792B2 (en) | 2007-09-11 | 2011-10-11 | University Of Massachusetts | Insulin-like growth factor binding protein 7 for treatment of cancer |
| US9089540B2 (en) * | 2008-01-31 | 2015-07-28 | Keio University | Method for determination of sensitivity to anti-cancer agent |
| US8093000B2 (en) * | 2008-05-09 | 2012-01-10 | The Regents Of The University Of California | Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation |
| WO2010135786A1 (en) * | 2009-05-29 | 2010-12-02 | Clinical Genomics Pty. Ltd. | A method for diagnosing neoplasms and molecules for use therein |
| KR20120048613A (ko) * | 2009-07-09 | 2012-05-15 | 아브락시스 바이오사이언스, 엘엘씨 | Ｓｐａｒｃ 안티센스 조성물과 이들의 용도 |
| DK177532B1 (en) | 2009-09-17 | 2013-09-08 | Bio Bedst Aps | Medical use of sPLA2 hydrolysable liposomes |
| EP2478362B1 (en) * | 2009-09-18 | 2016-05-11 | Abraxis BioScience, LLC | Use of the sparc microenvironment signature in the treatment of cancer |
| CN105699638B (zh) * | 2009-10-30 | 2018-05-22 | 学校法人庆应义塾 | 抗癌剂感受性的判定方法 |
| WO2011135459A2 (en) | 2010-04-29 | 2011-11-03 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
| DK2576638T3 (da) | 2010-05-25 | 2021-03-15 | Syndevrx Inc | Polymerkonjugerede metap2-inhibitorer og terapeutiske fremgangsmåder til anvendelse deraf |
| WO2011153485A2 (en) | 2010-06-03 | 2011-12-08 | Abraxis Bioscience, Llc | Use of the sparc microenvironment signature in the treatment of cancer |
| WO2012110425A1 (en) * | 2011-02-14 | 2012-08-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for monitoring the response to treatment and for treating colorectal cancer |
| US10260097B2 (en) * | 2011-06-02 | 2019-04-16 | Almac Diagnostics Limited | Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent |
| WO2013036850A2 (en) * | 2011-09-09 | 2013-03-14 | University Of Massachusetts | Modulation of midbody derivatives |
| AU2013353839A1 (en) | 2012-12-03 | 2015-06-18 | Almac Diagnostics Limited | Molecular diagnostic test for cancer |
| US9173956B2 (en) | 2013-04-10 | 2015-11-03 | Syndevrx, Inc. | METAP2 inhibitors and methods of treating obesity |
| GB201409479D0 (en) | 2014-05-28 | 2014-07-09 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
| CN103893763B (zh) * | 2014-04-10 | 2016-05-11 | 武汉大学 | Vinexin-β基因在心肌梗死中的应用 |
| CN106715332B (zh) * | 2014-07-21 | 2019-01-29 | 欧梭莱夫公司 | 用于治疗不孕症、促进雌性哺乳动物的正常繁殖和生育力及提高辅助生殖技术功效的钨盐 |
| WO2016046640A2 (en) | 2014-09-26 | 2016-03-31 | Medical Prognosis Institute A/S | Methods for predicting drug responsiveness |
| ES2893749T3 (es) | 2015-12-10 | 2022-02-10 | Syndevrx Inc | Derivados de fumagilol y polimorfos de los mismos |
| CA3008960C (en) * | 2016-01-11 | 2024-07-02 | Syndevrx, Inc. | TREATMENT OF TUMORS INDUCED BY METABOLIC DYSFUNCTION |
| US9725769B1 (en) | 2016-10-07 | 2017-08-08 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2017258901A1 (en) | 2016-12-30 | 2018-07-19 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
| US11696938B2 (en) * | 2017-11-21 | 2023-07-11 | Naofumi Miwa | Human cancer cell metastasis inhibitory agent and human cancer cell determination agent |
| EP3867641A1 (en) | 2018-10-15 | 2021-08-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Compounds for treatment of diseases and methods of screening therefor |
| WO2020087077A1 (en) | 2018-10-26 | 2020-04-30 | Syndevrx,Inc. | Biomarkers of metap2 inhibitors and applications thereof |
| WO2020163795A1 (en) | 2019-02-08 | 2020-08-13 | Dewpoint Therapeutics, Inc. | Methods of characterizing condensate-associated characteristics of compounds and uses thereof |
| WO2020232416A1 (en) * | 2019-05-15 | 2020-11-19 | Whitehead Institute For Biomedical Research | Methods of characterizing and utilizing agent-condensate interactions |
| CN110331203B (zh) * | 2019-07-30 | 2023-04-18 | 中南大学湘雅三医院 | 泛素连接酶chaf1b作为靶位点在制备肺腺癌顺铂增敏药物中的应用 |
| AU2020348383A1 (en) | 2019-09-18 | 2022-03-24 | Dewpoint Therapeutics, Inc. | Methods of screening for condensate-associated specificity and uses thereof |
| JP2024516162A (ja) * | 2021-04-26 | 2024-04-12 | クリチテック，インコーポレイテッド | シスプラチン粒子およびその使用 |
| US20250304625A1 (en) * | 2022-04-06 | 2025-10-02 | Vanderbilt University | Articles and methods for inhibiting methionine aminopeptidase activity |
| WO2025057928A1 (ja) * | 2023-09-11 | 2025-03-20 | 国立大学法人大阪大学 | 細胞外小胞内ｒｎａ修飾による卵巣癌プラチナ製剤抵抗性を判別するための検査方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08500481A (ja) | 1992-05-11 | 1996-01-23 | リボザイム・ファーマシューティカルズ・インコーポレーテッド | ウイルスの複製を阻害するための方法および薬剤 |
| JPH07509133A (ja) | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
| US5624803A (en) | 1993-10-14 | 1997-04-29 | The Regents Of The University Of California | In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom |
| US5902880A (en) | 1994-08-19 | 1999-05-11 | Ribozyme Pharmaceuticals, Inc. | RNA polymerase III-based expression of therapeutic RNAs |
| US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| US6146886A (en) * | 1994-08-19 | 2000-11-14 | Ribozyme Pharmaceuticals, Inc. | RNA polymerase III-based expression of therapeutic RNAs |
| CA2207593A1 (en) | 1994-12-13 | 1996-06-20 | John Gustofson | Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses |
| US6395713B1 (en) | 1997-07-23 | 2002-05-28 | Ribozyme Pharmaceuticals, Inc. | Compositions for the delivery of negatively charged molecules |
| JP2001510808A (ja) | 1997-07-24 | 2001-08-07 | イネックス ファーマシューティカルズ コーポレイション | 核酸触媒の供給のためのリポソーム組成物 |
| TW589189B (en) | 1997-08-04 | 2004-06-01 | Scras | Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis |
| JP2003528024A (ja) | 1997-12-16 | 2003-09-24 | バレンティス・インコーポレーテッド | 製剤化された核酸分子の無針注入 |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| US6680175B2 (en) * | 1998-05-05 | 2004-01-20 | Adherex Technologies, Inc. | Methods for diagnosing and evaluating cancer |
| GB9827152D0 (en) | 1998-07-03 | 1999-02-03 | Devgen Nv | Characterisation of gene function using double stranded rna inhibition |
| EP2314700A1 (en) | 1999-01-28 | 2011-04-27 | Medical College of Georgia Research Institute, Inc | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
| DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| AU767195B2 (en) | 1999-03-10 | 2003-11-06 | Phogen Limited | Delivery of substances to cells |
| WO2001012781A1 (en) * | 1999-08-13 | 2001-02-22 | Human Genome Sciences, Inc. | 13 human colon and colon cancer associated proteins |
| WO2001029058A1 (en) | 1999-10-15 | 2001-04-26 | University Of Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| GB9927444D0 (en) | 1999-11-19 | 2000-01-19 | Cancer Res Campaign Tech | Inhibiting gene expression |
| WO2001061048A2 (en) * | 2000-02-17 | 2001-08-23 | Millennium Pharmaceuticals, Inc. | Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| US7279294B2 (en) * | 2000-04-03 | 2007-10-09 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services, Nih | Tumor markers in ovarian cancer |
| WO2002014554A2 (en) * | 2000-08-11 | 2002-02-21 | City Of Hope | The anti-neoplastic agent et-743 inhibits trans activation by sxr |
| US20040096915A1 (en) * | 2000-10-27 | 2004-05-20 | Diamandis Eleftherios P. | Methods for detecting ovarian cancer |
| US20020182619A1 (en) * | 2000-11-08 | 2002-12-05 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer |
| US7195868B2 (en) * | 2001-04-18 | 2007-03-27 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the identification, assessment, prevention, and therapy of human cancers |
| EP1451343B1 (en) * | 2001-11-02 | 2012-10-17 | Dana-Farber Cancer Institute | Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof |
| US7250271B2 (en) * | 2001-11-28 | 2007-07-31 | David Waisman | Anti-angiogenesis methods, compositions and uses therefor |
| US7341552B2 (en) * | 2002-03-15 | 2008-03-11 | The University Of Texas System Board Of Regents | Gene sets for glioma classification |
| US20040097452A1 (en) * | 2002-11-19 | 2004-05-20 | Isis Pharmaceuticals Inc. | Modulation of kallikrein 6 expression |
| CN102989009B (zh) * | 2003-12-31 | 2015-06-03 | 宾夕法尼亚州研究基金会 | 预测并克服对卵巢癌化疗的抗性的方法及预测结肠癌发生的方法 |
| EP1828768A4 (en) * | 2004-08-13 | 2009-05-06 | Jaguar Bioscience Inc | SYSTEMS AND METHODS FOR IDENTIFYING DIAGNOSTIC INDICATORS |
-
2004
- 2004-12-30 CN CN201210472073.1A patent/CN102989009B/zh not_active Expired - Fee Related
- 2004-12-30 JP JP2006547537A patent/JP4682152B2/ja not_active Expired - Fee Related
- 2004-12-30 ES ES04815833T patent/ES2394799T3/es not_active Expired - Lifetime
- 2004-12-30 CN CN201110195193.7A patent/CN102321584B/zh not_active Expired - Fee Related
- 2004-12-30 EP EP04815833A patent/EP1704250B1/en not_active Expired - Lifetime
- 2004-12-30 WO PCT/US2004/043837 patent/WO2005066371A2/en not_active Ceased
- 2004-12-30 CN CN2004800421486A patent/CN1922332B/zh not_active Expired - Fee Related
- 2004-12-30 US US11/026,734 patent/US7700280B2/en not_active Expired - Lifetime
- 2004-12-30 EP EP11163049.7A patent/EP2395112B1/en not_active Expired - Lifetime
- 2004-12-31 TW TW093141829A patent/TWI301066B/zh not_active IP Right Cessation
-
2010
- 2010-02-23 US US12/711,056 patent/US20100221730A1/en not_active Abandoned
- 2010-02-23 US US12/711,068 patent/US8192935B2/en not_active Expired - Fee Related
- 2010-02-23 US US12/711,036 patent/US20100221729A1/en not_active Abandoned
- 2010-03-31 JP JP2010081265A patent/JP5285012B2/ja not_active Expired - Fee Related
-
2012
- 2012-12-12 JP JP2012271426A patent/JP5789591B2/ja not_active Expired - Fee Related
-
2016
- 2016-02-24 US US15/052,422 patent/US20160348180A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010209076A5 (enExample) | ||
| JP7706728B2 (ja) | 胆道がんの検出キット又はデバイス及び検出方法 | |
| Győrffy et al. | RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data | |
| JP7228896B2 (ja) | 乳がん患者の予後の予測方法 | |
| JP6991433B2 (ja) | 肺がんの検出キット又はデバイス及び検出方法 | |
| Pedersen et al. | MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma | |
| JP2010516291A5 (enExample) | ||
| JP2019516407A5 (enExample) | ||
| JP2014516543A5 (enExample) | ||
| JP2012503985A5 (enExample) | ||
| JP2012510813A5 (enExample) | ||
| Liu et al. | Single nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma | |
| WO2012093821A2 (ko) | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 | |
| DK3141617T3 (en) | PROCEDURE FOR PREVENTING THE CANCER OF A CANCER ON A PATIENT BY ANALYZING GENEPRESSION | |
| JP2010518811A5 (enExample) | ||
| Izquierdo et al. | Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma | |
| JP6164689B2 (ja) | 乳癌術前化学療法に対する感受性の診断補助方法および判定装置 | |
| JP2011528903A5 (enExample) | ||
| TW201309805A (zh) | 預測大腸直腸癌復發的生物標記 | |
| RU2018122965A (ru) | Улучшенный способ и набор для определения тяжести и прогрессирования периодонтального заболевания | |
| Sulman et al. | Beyond grade: molecular pathology of malignant gliomas | |
| JP2014221834A5 (enExample) | ||
| JP2018507692A (ja) | マイクロｒｎａに基づく前立腺がん患者の予後評価方法 | |
| CN113444804A (zh) | 宫颈癌预后相关基因及其在制备宫颈癌预后预测诊断产品中的应用 | |
| Goulter et al. | Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue |